Provided by Tiger Trade Technology Pte. Ltd.

Nurix Therapeutics

26.04
+0.26001.01%
Volume:1.60M
Turnover:41.39M
Market Cap:2.69B
PE:-7.64
High:26.11
Open:25.47
Low:25.47
Close:25.78
52wk High:28.23
52wk Low:8.20
Shares:103.41M
Float Shares:95.05M
Volume Ratio:1.55
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4102
EPS(LYR):-3.0514
ROE:-80.30%
ROA:-40.06%
PB:6.69
PE(LYR):-8.53

Loading ...

Nurix Therapeutics is Maintained at Buy by UBS

Dow Jones
·
Jul 23

UBS Lifts Nurix Therapeutics Price Target to $31 From $23, Maintains Buy Rating

MT Newswires Live
·
Jul 22

Nurix Therapeutics, Roche Partner to Co-develop BTK Degrader Bexobrutideg in Deal Worth up to $2.3 Billion

Reuters
·
Jul 22

Nurix Therapeutics Announces Hsr Clearance of Global Collaboration with Roche to Co-develop and Co-commercialize Potential Best-in-class Btk Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

THOMSON REUTERS
·
Jul 22

Nurix Therapeutics - Co and Roche to Jointly Advance Bexobrutideg in Cll, B-cell Malignancies, MS, and Csu

THOMSON REUTERS
·
Jul 22

Nurix Therapeutics - to Receive $700 Mln Upfront, up to $2.30 Bln in Total Potential Payments

THOMSON REUTERS
·
Jul 22

Nurix Therapeutics - Development Costs Shared 40% Nurix, 60% Roche; U.S. Profits and Losses Split Equally

THOMSON REUTERS
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Axsome Therapeutics (AXSM) and Nurix Therapeutics (NRIX)

TIPRANKS
·
Jul 14

Mizuho Raises Price Target on Nurix Therapeutics to $34 From $30, Keeps Outperform Rating

MT Newswires Live
·
Jul 13

Nurix Therapeutics' Roche Deal Seen Driving Long-Term Upside, RBC Capital Markets Says

MT Newswires Live
·
Jul 10

Oppenheimer Sticks to Its Buy Rating for Nurix Therapeutics (NRIX)

TIPRANKS
·
Jul 10

Nurix Therapeutics price target raised to $40 from $34 at Stifel

TIPRANKS
·
Jul 10

RBC Capital Raises Nurix Therapeutics Price Target to $33 From $30, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Jul 10

Nurix Therapeutics is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 10

Nurix Therapeutics Q2 Revenue Falls Sharply, Net Loss Widens; Strikes up to $2.3 Bln Collab with Roche

Reuters
·
Jul 10

Nurix Therapeutics reports Q2 EPS (81c), consensus (72c)

TIPRANKS
·
Jul 10

Nurix Therapeutics Q2 EPS $(0.81) Misses $(0.74) Estimate, Sales $9.043M Miss $16.170M Estimate

Benzinga Earnings
·
Jul 10

Nurix Net Loss Widens to $89.5 Million in Q2 FY26; Revenue Drops to $9 Million

Reuters
·
Jul 10

Nurix Therapeutics Q2 Operating Expenses USD 103.247 Million

THOMSON REUTERS
·
Jul 10

Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Jul 10